Stem cell therapy has emerged as a potential therapeutic option for cell death-related heart diseases. Application of non-invasive cell tracking approaches is necessary to determine tissue distribution and lifetime of stem cells following their injection and will likely provide knowledge about poorly understood stem cells mechanisms of tissue repair. Magnetic resonance imaging (MRI) is a potentially excellent tool for high-resolution visualization of the fate of cells after transplantation and for evaluation of therapeutic strategies. The application of MRI for in vivo cell tracking requires contrast agents to achieve efficient cell labeling without causing any toxic cellular effects or eliciting any other side effects. For these reasons clinically approved contrast agents (e.g., ferumoxides) and incorporation facilitators (e.g., protamine) are currently the preferred materials for cell labeling and tracking. Here we describe how to use superparamag-netic iron oxide nanoparticles to label cells and to monitor cell fate in several disease models.
Introduction
Stem cell therapy has emerged as a therapeutic option in several types of injury and disease. However, the lack of data concerning the distribution and engraftment of the cells presents a serious obstacle for the successful application of stem cell therapies in patients. Thus, the development of sensitive, non-invasive techniques for serially tracking cells will likely provide knowledge about the poorly understood mechanisms responsible for the reported improvement in several lesion/disease models (1) (2) (3) . Magnetic resonance imaging (MRI) offers an imaging modality with high-resolution to visualize the fate of cells after transplantation and to evaluate cell-based repair, replacement, and therapeutic strategies (4) (5) (6) (7) (8) .
Several paramagnetic contrast agents have been successfully used for in vivo cell tracking and labeling of different mammalian cell types (1, (9) (10) (11) (12) . Ferumoxides, such as Feridex IV (Advanced Magnetics Inc., USA) and Endorem (Guerbet SA, France) are dextran-coated superparamagnetic iron oxide nanoparticles (SPIONs) clinically used to provide intravenous MRI contrast in order to analyze liver pathology. The particles are biodegradable and all the degradation products can be incorporated in normal metabolic processes (13) . SPIONs, however, tend to aggregate, but this can be minimized by their coating with dextran or other polymers (14) . Other types of human approved contrast agents have also been used to label and track transplanted cell, such as ferucarbotran (Resovist) and gadoliniun nanoparticles (15, 16) . However, there have been reports that gadolinium based agents may adversely affect the labeled cells (17, 18) .
The dextran-coated SPIONs do not show sufficient cellular uptake to enable tracking of nonphagocytic cells. However, uptake of SPIONs can be facilitated by incubation with cationic compounds such as poly-L-lysine (PLL) (19) (20) (21) , protamine sulfate (21-24), FuGENE (3), Superfect or Lipofectamine (12) . The primary advantage of the incubation labeling method is its simplicity. The primary disadvantage is the extended incubation time (4 h or more) required (25) . Thus, other approaches to induce labeling of freshly isolated cells such as magnetoelectroporation (26, 27) and magnetosonoporation (28) offer alternative protocols and are preferable when the culture system must be avoided. Nevertheless, for adherent cells that can be maintained in culture, PLL and protamine are the most frequently used agents to facilitate the incorporation of SPIONs.
PLL is a synthetic cationic polymer commonly used to enhance cell adhesion to the surface of culture dishes. Its use has not yet been approved in humans and studies have shown that complexes formed by ferumoxides and PLL (FePLL) can be large. Such large complexes do not become incorporated into endosomes and, instead, remain adhered to the cell membrane (22, 29) . These complexes can affect cell proliferation (21) and differentiation (30) . Protamines are low-molecular-weight arginine-rich proteins (~4,000 Da), that are purified from the mature fish testis. Protamine is a clinically approved polycationic peptide primarily used as an antidote for heparin anticoagulation (31, 32) .
Approval for clinical tracking of labeled stem cells by MRI depends on efficient cell labeling that does not cause toxic cellular effects and does not elicit side effects. Ferumoxide and protamine are the currently favored materials for cell labeling and tracking because of the following advantages: Efficiency of cell tracking by MRI, commercial availability, approval for human use, and the lack of toxic effects on biological properties of cells. Besides, recent studies have shown that the number of labeled cells or the amount of intracellular SPIONs in cells exposed to FeProt complexes for 4 h is the same as at 24 h (21) and 48 h (23).
Here we describe procedures for making FeProt complexes (derivatized SPION nanoparticles), techniques for labeling adherent cells with FeProt complexes and microscopy and MRI-based methods for analysis of incorporation efficiency of the SPIONs' incorporation efficiency. both solutions together, cover tube with aluminum foil to protect it from the light and shake until the reagents are completely dissolved. The final volume depends on the number of wells used, e.g. for each well of a 24-well plate prepare 300 μL. The solution should be prepared fresh.
3.
Nuclear Fast Red (1 %): dilute 0.02 g of Nuclear Fast Red in 2 mL of deionized water, mix, and then filter through filter paper to eliminate large particles.
4. Absolute ethanol.
5.
Ethanol (70 and 30 %): dilute 70 or 30 mL of absolute ethanol with 30 or 70 mL of deionized water, respectively.
6. Xylene.
7.
Ethanol/xylene mixture (1:1, v/v): made by mixing equal volume of absolute ethanol and xylene.
8.
Entellan mounting medium (Merck KGaA, Darmstadt, Germany, cat. # UN 1866).
Immunostaining with Anti-dextran Antibody (See Note 5)
1. PBS with 0.1 % Triton X-100: dilute 200 μL of Triton X-100 in 200 mL of PBS and mix well.
2.
Normal goat serum (5 %): dilute 1 mL of normal goat serum in 19 mL of PBS and mix well. This solution can be stored in aliquots at −20 °C, if thawed it can be refrozen and thawed several times.
3.
Anti-dextran antibody (1:1,000): dilute the anti-dextran mouse monoclonal antibody (Stem Cell Technologies, Vancouver, BC, USA, cat. # 01403) 1:1,000 (v:v) with PBS/0.1 % Triton X-100. Prepare the primary antibody fresh each time, but leftover material can be stored protected from light at 4 °C and used within a week.
4.
Goat anti-mouse IgG secondary antibody: dilute the goat-anti-mouse IgG (e.g., Alexa Fluor 488 labeled, available from Invitrogen Inc.) in PBS/0.1 % Triton X-100 at 1:400 (v:v) (see Note 7). The ratio of antibody to PBS depends on the antibody brand. Prepare the secondary antibody fresh each time, but the leftover can be stored protected from light at 4 °C and used within a week.
5. 4′,6-Diamidino-2-phenylindole (DAPI) stock solution (1 mg/mL): dissolve 1 mg of DAPI in 1 mL of distilled water.
6. DAPI working solution (10 μg/mL): add 0.1 mL of 1 mg/mL DAPI stock solution into 9.9 mL of PBS (see Note 8) . These solutions can be kept at 4 °C for months, protected from light.
7.
Vectashield mounting medium for fluorescence (Vector Laboratories Inc., Burlingame, CA, USA, cat. # H-1000) (see Note 8).
8. Nail polish for sealing the coverslips.
Preparing Cells for In Vitro MRI
1. Use 1.5 mL tubes, 96-or 24-well plates (see Note 9).
6 In this step is important to put the water into the vessel before the acid. 7 Other secondary antibody brands can be use but the ratio of antibody to PBS depends on the chosen antibody brand. 8 As an alternative for a separate DAPI solution, the Vectashield mounting medium can be replaced by Vectashield mounting medium for fluorescence containing DAPI (Vector Laboratories Inc., cat. # H-1200).
2. 15 % Gelatin: dilute 1.5 g of gelatin in 10 mL of distilled water. Use a water bath, at 60 °C, and the vortex to dissolve this solution. With the gelatin still hot, quickly make aliquots of 200 μL in 1.5 mL tubes, 96-or 24-well plates. Always prepare a fresh solution and only prepare it when the cells are ready to be mixed (as described in Subheading 3.3.3).
Analyzing the Labeling Efficacy by Microscopy

1.
Light microscope equipped with a color camera for recording Prussian Blue images.
2.
Fluorescence microscope (e.g., Axiovert 200M, Zeiss, GmbH) equipped with a camera for immunostaining experiments. For quantification, we recommend using a ×20 magnification objective.
Analyzing the Labeling Efficacy by MRI
1.
For MRI an MRI scanner with appropriately sized imaging coils is required. We used a 9.4 T vertical bore system with a microimaging accessory but a horizontal research magnet or lower field clinical magnet could also be used (see Note 10).
2.
Dedicated spectrometer software or other analysis programs such as Image J (from U.S. National Institutes of Health, http://rsbweb.nih.gov/ij/), and MATLAB (The Mathworks, Natick, MA) based programs are required to evaluate intensity differences between samples.
Methods
Carry out all procedures at room temperature unless otherwise specified.
Labeling of Adherent Cells (See Note 11)
The experimental procedures are summarized in Fig. 1 . The effect of protamine on cell labeling is illustrated in Fig. 2 .
1.
Preparing the labeling solution: the final concentrations of SPIONs and protamine are 50 and 5 μg/mL respectively. These should always be prepared fresh as described below. Figure 2 illustrates the importance of using the recommended concentrations of SPIONs and protamine.
2.
For preparation of 4 mL of labeling solution (see Note 12): transfer 2 mL of FBSsupplemented culture medium (see Note 2) to a 15 mL conical tube, add 18 μL of SPIONs and 2 μL of protamine. Transfer the tube containing the labeling solution to a shaker and gently shake for 30 min at room temperature. Subsequently, add 2 mL more of culture medium to the labeling solution (1:1, v:v) and very gently mix the solution using a P1000 pipette.
3.
Replace the culture medium with labeling solution and maintain the cells in the incubator in 5 % CO 2 atmosphere at 37 °C for 4 h. 9 We have prepared the gelatin aliquots in 1.5 mL tubes because our MRI system is a vertical bore with a limited coil size that does not accommodate 24-or 96-well flat plates. However for a horizontal MRI system a plate may be more convenient. 10 For our study we used a 9.4 T magnet and imaged four 1.5 mL tubes of labeled cells at a time by mounting the tubes within a 50 mL conical tube and positioning that in a 40 mm birdcage imaging coil. We used a spin-echo sequence with a slice thickness of 0.5 mm, TR = 1 s, TE = 15 ms, and acquired four contiguous slices (Fig. 4b) . 11 We recommend using the cells at 80-90 % confluence, regardless of the size of the culture plates. 12 4 mL of labeling solution is needed for each 100 mm Petri dish plate.
Gently and quickly wash three times with PBS for elimination of non-incorporated SPIONs (no extended incubation with PBS is necessary)
. At this point the cells are ready to be fixed for Prussian Blue and/or immunostaining or to be transplanted (see Note 1) or detected in vitro by MRI.
Fixing Cells for Evaluation by Staining
1.
Transfer coverslips into the wells of a 24-well plate, add 300 μL of 0.2 % gelatin to cover the coverslips and incubate for 10 min at room temperature or in the incubator at 37 °C. Aspirate the gelatin and maintain the plate for another 10 min at room temperature or in the incubator at 37 °C, at this point the plate is ready to receive the culture medium and the cells (see Note 13).
2.
For SPION incorporation in 24-well plate use the same protocol as detailed above for 100 mm dish plate, but scale all components down. The final volumes to use are 300 μL of medium, 1.3 μL of SPIONs and 0.15 μL of protamine for each well.
3.
To fix the cells, add 300 μL of 4 % formaldehyde to cover the coverslips in the 24-well plate and incubate for 20 min at 37 °C or at room temperature. Remove the formaldehyde and gently and quickly wash two times with PBS. At this point the cells are attached to coverslips and are ready to be stained.
4.
To store the fixed cells, fill the wells with PBS and store plates at 4 °C for up to several months (see Note 14).
Determining Labeling Efficiency
Below we describe how to detect the SPIONs by Prussian Blue and/or immunostaining (Fig.  3) , and how to prepare the cells for in vitro MRI (Fig. 4 ) (see Note 4).
Prussian Blue Staining
1.
Wash the coverslips with fixed cells in 24-well plate twice with deionized water for 5 min and incubate with Perl's solution for 20 min.
2.
Quickly wash the cells once with deionized water, incubate with 1 % Nuclear Fast Red for 5 min for nuclei counterstaining, and then quickly wash once more.
3.
Dehydrate the cells using quick washes with 35 % ethanol, followed by 70 % ethanol and absolute ethanol. Immediately after that, quickly wash the cells once with the absolute ethanol:xylene (1:1) solution and twice with xylene alone (see Note 15) to remove the alcohol.
4.
Mount the cover slips in slides with a drop of Entellan mounting medium, avoid having thick Entellan layer (see Note 16) . Allow the mounting medium to dry (usually 20-30 min) at which time the cells are ready for imaging.
3. Count the number of labeled cells. To estimate the percentage efficiency, divide the number of labeled cells by the total number of cells counted.
Analyzing the Labeling Efficiency by MRI
Contrast in MRI depends on the relaxation properties of the 1 H nuclei, mainly in water, in the cells and tissues. Longitudinal relaxation, T1, is the time it takes for the 1 H nuclei to relax back to their equilibrium value after perturbation with a radiofrequency pulse. Transverse or spin-spin relaxation, T2 and T2* (T2* includes additional effects caused by inhomogeneities in the static magnetic field), results from molecular interactions and causes a loss of detectable magnetization. T1, T2 and T2* weighted imaging methods are designed to detect differences in the relaxation properties, thus, a fluid filled cyst will appear bright on a T2-weighted image and dark on a T1-weighted image because it has long T2 and T1 relaxation times. On the other hand, a solid mass, having a short T2 and long T1, will appear bright on a T2-weighted image but dark on a T1-weighted image. In contrast, fat appears bright in T1-weighted images and dark in T2-weighted images because it has short T1 and T2 relaxation times. SPIONs, such as ferumox-ides, are negative contrast agents. They cause a reduction in the T2 and T2* relaxation time of the nearby water (see Note 20) and appear dark in T2-weighted images. Thus detection of SPION labeled cells by MRI is typically accomplished using T2-weighted imaging methods.
1.
Optimize magnetic field homogeneity of the cell sample and adjust MRI parameters (echo time and repetition time for optimal contrast). Although a spinecho imaging sequence can be used, the T2* weighted gradient echo imaging sequence is recommended, particularly at higher field (~9.4 T) (see Note 21).
2.
Acquire several thin (0.5 mm) contiguous image slices with optimized imaging parameters (see Note 10).
3.
Quantify mean intensity of the cells to determine labeling efficiency. Use software provided by the MRI manufacturer, or free software, such as ImageJ. The image file is read into the software and the region of interest containing the labeled cells is selected. The intensities of all pixels within the region of interest are calculated and minimum, maximum and mean intensity is reported. Depending on the sample configuration several image slices may be analyzed and the results averaged. 
